Business and Europe: The Reform Agenda
Date
Section
Event Location
Event Description
Pro Europa (www.proeuropa.org.uk) invites for a conference with Simon Walker, the Director-General of the Institute of Directors (IoD) “Business and Europe: the reform agenda”
Date and time: Wednesday, 10th September 2014 at 7.00 pm
The honorary guest: Simon Walker, Director-General of the Institute of Directors (IoD), former Chief Executive of the BVCA, Director of Corporate Communications and Marketing at Reuters, and Communications Secretary to HM The Queen at Buckingham Palace.
Venue: the British Chamber of Commerce, boulevard Bischoffsheim 11, 1000, Brussels.
Number of places is limited and the priority is given to members of Pro Europa.
RSVP: office@proeuropa.org.uk
Related Events
Securing Europe‘s Raw Material Supply in the Context of Resource Efficiency and EU Industry Policy
There is no energy- and resource efficiency, no climate protection, no future technologies for our modern
world without the use of non-ferrous metals.
Monday 5 November 2012 (day 1)
15:00-16:30: European Parliament Briefing (optional): Enterprise Forum members will have the opportunity to attend a briefing on how the European Parliament works. Paul-Henri Spaak Building, Rue Wiertz, B-1047 Brussels
SMEs are the backbone of the European economy. Of the approximately 20 million SMEs in Europe, one third is active in the field of commerce.
COST will be a partner of the fourth European Innovation Summit to be held at the European Parliament in Brussels under the motto 'Building bridges – Creating Synergies'.
Knowledge4Innovation will be organising the 4th European Innovation Summit from 9 to 10 October 2012 in the European Parliament in Brussels.
An existing literature agrees that drug innovation has a significant average effect on extending longevity and improving quality of life. Recognizing the life-saving benefits from the development of new drugs, one of the key decisions faced by the authorities is how to bolster pharmaceutical innovation, and how to bear in mind the potential effects on drug innovation of policies that affect market size, such as policies towards intellectual property rights, procurement mechanisms and competition policy.
Pages
Events of the week
Jobs
EURACTIV News
- European Commission demands information from Temu over illegal goods
- The new Meta-tied DSA body, Council draft hints at e-Privacy review
- Nobel Peace Prize goes to Japanese nuclear bombs survivors’ movement
- Europe’s e-commerce strong growth challenges China, US dominance
- Lithuania to pick new parliament in election clouded by economic angst, Russia fears